Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma (Q38803932)

6 September 2017

title

Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma (English)

1 reference

6 September 2017

Yun Gao

1

1 reference

6 September 2017

Zhong Zhou

2

1 reference

6 September 2017

Sen Lu

3

1 reference

6 September 2017

Xinli Huang

4

1 reference

6 September 2017

Chuanyong Zhang

5

1 reference

6 September 2017

Runqiu Jiang

6

1 reference

6 September 2017

Aihua Yao

7

1 reference

6 September 2017

Beicheng Sun

8

1 reference

6 September 2017

Xuehao Wang

9

1 reference

6 September 2017

publication date

13 January 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

34

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

1112-1122

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

6 September 2017

copyright license

start time

11 November 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Hepatocellular carcinoma

1 reference

Management of Hepatocellular Carcinoma: Current Status and Future Directions

21 January 2018

1 reference

Cancer gene therapy using mesenchymal stem cells

21 January 2018

1 reference

Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.

21 January 2018

1 reference

Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.

21 January 2018

1 reference

Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium

21 January 2018

1 reference

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

21 January 2018

1 reference

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu

21 January 2018

1 reference

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo

21 January 2018

1 reference

Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas

21 January 2018

1 reference

Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.

21 January 2018

1 reference

Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice

21 January 2018

1 reference

Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors

21 January 2018

1 reference

Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma

21 January 2018

1 reference

Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery

21 January 2018

1 reference

Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma

21 January 2018

1 reference

CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma

21 January 2018

1 reference

Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo

21 January 2018

1 reference

Identification of serum CCL15 in hepatocellular carcinoma

21 January 2018

1 reference

Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1 myeloid cells and facilitate liver metastasis

21 January 2018

1 reference

Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer

21 January 2018

1 reference

Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta

21 January 2018

1 reference

Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss

21 January 2018

1 reference

Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells

21 January 2018

1 reference

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors

21 January 2018

1 reference

Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft

21 January 2018

1 reference

Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival

21 January 2018

1 reference

NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites

21 January 2018

1 reference

Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?

21 January 2018

1 reference

Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.2275

1 reference

6 September 2017

1 reference